SNY — Sanofi

Median target
$50
calls from the last 12 months
Implied return
+10.3%
median target vs. price
Coverage
6 analysts · 6 calls
updated in the last 12 months
Consensus
0/6/00 net
Buy / Hold / Sell

Which analysts are behind SNY's consensus?

See every current rating, price target and the analysts' track records for Sanofi — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 6 analysts with calls on SNY updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

SNY elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2025-09-11CongressLisa McClainMI-MI09Salesince trade -4.9%, vs market +20.5%$1K–$15K
2025-07-22CongressLisa McClainMI-MI09Salesince trade -7.0%, vs market +28.0%$1K–$15K
2025-06-17CongressLisa McClainMI-MI09Purchasesince trade -6.0%, vs market -33.7%$1K–$15K
2025-04-28ExecutiveLandau, ChristopherDeputy SecretarySaleSanofi (SNY)$15,001 - $50,000
2023-11-10CongressJohn JamesMI-MI10Purchasesince trade +7.5%, vs market -69.2%$1K–$15K
2022-05-27CongressEarl BlumenauerOR-OR03Purchasesince trade -7.2%, vs market -99.1%$15K–$50K
2022-03-16CongressJohn RutherfordFL-FL04Salesince trade +2.5%, vs market +81.0%$1K–$15K
2020-03-19CongressGreg GianforteMT-MT00Purchasesince trade +41.0%, vs market -202.2%$1K–$15K
2019-03-25CongressNicholas Van TaylorTX-TX03Salesince trade +35.8%, vs market +164.3%$15K–$50K
2018-12-03CongressJohn RutherfordFL-FL04Salesince trade +33.9%, vs market +169.0%$1K–$15K

More: congressional trades on SNY · insider activity · executive branch · trending